Commonwealth Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Commonwealth Financial Services's VRTX Position: Q2 2026 in Review
Commonwealth Financial Services opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 457 shares worth $227K. The stake represents 0.03% of the portfolio and ranks #265 among its holdings. This is a return to the name: Commonwealth Financial Services previously reported a position in VRTX as recently as Q4 2025.
Commonwealth Financial Services first reported a position in VRTX in Q3 2024 and has held it in 5 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Commonwealth Financial Services held 457 shares of Vertex Pharmaceuticals worth $227K as of Q2 2026.
- Vertex Pharmaceuticals was a new Commonwealth Financial Services position in Q2 2026.
- Vertex Pharmaceuticals made up 0.03% of Commonwealth Financial Services's portfolio in Q2 2026, its #265 holding.
- Commonwealth Financial Services first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Commonwealth Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.